Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Mesa Laboratories (MLAB) just unveiled an update.
Mesa Laboratories, Inc. recently revised its senior secured credit agreement with a banking syndicate led by JPMorgan Chase, enhancing its financial flexibility. The modifications include a new $75 million term loan, an extended credit facility maturity to April 2029, and adjustments to financial covenants. The company also retains a $125 million revolving credit facility to support its working capital and corporate needs, including potential acquisitions. Additionally, Mesa has negotiated the repurchase of $75 million of its 1.375% Convertible Notes due in 2025, reducing its outstanding debt and streamlining its capital structure.
For a thorough assessment of MLAB stock, go to TipRanks’ Stock Analysis page.
